Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
Hum Vaccin Immunother ; 20(1): 2341454, 2024 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-38695296

RESUMEN

Pertussis is a vaccine-preventable infectious disease; however, data on pertussis antibody levels in a nationwide population are still limited in China. We aimed to pool the seropositivity rates of IgG antibodies against pertussis toxin (PT-IgG) across the country. We systematically searched PubMed, Web of Science, Embase, and the China National Knowledge Infrastructure Database for studies published between January 1, 2010, and June 30, 2023. Studies reporting the seroprevalence of PT-IgG among a healthy Chinese population were included. Pooled estimates were obtained using random-effects meta-analyzes. The meta-analysis included 39 studies (47,778 participants) reporting anti-PT IgG seropositivity rates. The pooled rate for all ages was 7.06% (95% CI, 5.50%-9.07%). Subgroup analyzes showed rates ranging from 6.36% to 12.50% across different age groups. This meta-analysis indicated a low anti-PT IgG seropositivity rate in the Chinese population, particularly among school-aged children and young adults. This finding underscores the urgent need to refine immunization strategies.


Asunto(s)
Anticuerpos Antibacterianos , Inmunoglobulina G , Toxina del Pertussis , Tos Ferina , Humanos , Estudios Seroepidemiológicos , Toxina del Pertussis/inmunología , Inmunoglobulina G/sangre , Tos Ferina/epidemiología , Tos Ferina/inmunología , Tos Ferina/prevención & control , China/epidemiología , Anticuerpos Antibacterianos/sangre , Niño , Adulto , Adulto Joven , Adolescente , Preescolar , Persona de Mediana Edad , Vacuna contra la Tos Ferina/inmunología , Vacuna contra la Tos Ferina/administración & dosificación , Pueblos del Este de Asia
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda